Conditions and drugs interfering with thyroxine absorption.Best Pract Res Clin Endocrinol Metab. 2009 Dec; 23(6):781-92.BP
Abstract
Food, dietary fibre and espresso coffee interfere with the absorption of levothyroxine. Malabsorptive disorders reported to affect the absorption of levothyroxine include coeliac disease, inflammatory bowel disease, lactose intolerance as well as Helicobacter pylori (H. pylori) infection and atrophic gastritis. Many commonly used drugs, such as bile acid sequestrants, ferrous sulphate, sucralfate, calcium carbonate, aluminium-containing antacids, phosphate binders, raloxifene and proton-pump inhibitors, have also been shown to interfere with the absorption of levothyroxine.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
19942153
Citation
Liwanpo, Llanyee, and Jerome M. Hershman. "Conditions and Drugs Interfering With Thyroxine Absorption." Best Practice & Research. Clinical Endocrinology & Metabolism, vol. 23, no. 6, 2009, pp. 781-92.
Liwanpo L, Hershman JM. Conditions and drugs interfering with thyroxine absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781-92.
Liwanpo, L., & Hershman, J. M. (2009). Conditions and drugs interfering with thyroxine absorption. Best Practice & Research. Clinical Endocrinology & Metabolism, 23(6), 781-92. https://doi.org/10.1016/j.beem.2009.06.006
Liwanpo L, Hershman JM. Conditions and Drugs Interfering With Thyroxine Absorption. Best Pract Res Clin Endocrinol Metab. 2009;23(6):781-92. PubMed PMID: 19942153.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Conditions and drugs interfering with thyroxine absorption.
AU - Liwanpo,Llanyee,
AU - Hershman,Jerome M,
PY - 2009/11/28/entrez
PY - 2009/11/28/pubmed
PY - 2010/2/13/medline
SP - 781
EP - 92
JF - Best practice & research. Clinical endocrinology & metabolism
JO - Best Pract Res Clin Endocrinol Metab
VL - 23
IS - 6
N2 - Food, dietary fibre and espresso coffee interfere with the absorption of levothyroxine. Malabsorptive disorders reported to affect the absorption of levothyroxine include coeliac disease, inflammatory bowel disease, lactose intolerance as well as Helicobacter pylori (H. pylori) infection and atrophic gastritis. Many commonly used drugs, such as bile acid sequestrants, ferrous sulphate, sucralfate, calcium carbonate, aluminium-containing antacids, phosphate binders, raloxifene and proton-pump inhibitors, have also been shown to interfere with the absorption of levothyroxine.
SN - 1878-1594
UR - https://www.unboundmedicine.com/medline/citation/19942153/full_citation
L2 - https://linkinghub.elsevier.com/retrieve/pii/S1521-690X(09)00076-1
DB - PRIME
DP - Unbound Medicine
ER -
